Mind Medicine Inc (NAS:MNMD)
$ 8.19 -0.78 (-8.7%) Market Cap: 600.59 Mil Enterprise Value: 438.17 Mil PE Ratio: 0 PB Ratio: 2.93 GF Score: 41/100

Q1 2022 Mind Medicine (MindMed) Inc Earnings Call Transcript

May 16, 2022 / 12:30PM GMT
Release Date Price: $12.01 (+2.64%)
Operator

Good morning, and welcome to the Mind Medicine first-quarter 2022 financial results and corporate update conference call. (Operator Instructions) This call is being webcast live on investors and media section of my meds website at mindmed.co and recording will be available after the call.

For opening remarks, I would like to introduce Rob Barrow, CEO of MindMed. Please go ahead, sir.

Rob Barrow;MindMed;Inc.;CEO;Director
Mind Medicine

()-&

Thank you, and good morning. I appreciate everyone joining us for our first-quarter 2022 financial results and corporate update conference call. The press release reporting our financial results is available in the investors and media section of MindMed's website. And our quarterly report on Form 10-Q for the quarter ended March 31, 2020, will be filed today with the Securities and Exchange Commission.

Joining me today Dr. Daniel Karlin, our Chief Medical Officer; and Dr. Miri Halperin Wernli, our Executive President.

During today

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot